JDJIX | MBXFX | JDJIX / MBXFX | |
Total Expense Ratio | 1.36 | 3.03 | 45% |
Annual Report Gross Expense Ratio | 1.37 | 3.03 | 45% |
Fund Existence | 6 years | 5 years | - |
Gain YTD | -5.420 | -2.608 | 208% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 2500 | 10,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.34B | 8.05B | 17% |
Annual Yield % from dividends | 0.45 | 1.17 | 39% |
Returns for 1 year | -11.66 | -2.00 | 584% |
Returns for 3 years | -8.83 | 4.52 | -195% |
Returns for 5 years | 13.90 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SBHIX | 22.87 | N/A | N/A |
Saratoga Health & Biotechnology I | |||
AFGPX | 18.11 | N/A | N/A |
Alger International Opportunities B | |||
GSMQX | 18.52 | N/A | N/A |
Goldman Sachs Small/Mid Cap Growth Svc | |||
JLCWX | 70.51 | N/A | N/A |
JHancock Fundamental Large Cap Core R6 | |||
WSCRX | 33.77 | N/A | N/A |
Allspring Small Company Growth R6 |